Longitudinal Study Of The Evoked Compound Action Potential Measured In Children Cochlear Implant Users

Introduction: In Cochlear Implant (CI) users, the recording of the electrically evoked compound action potential (ECAP) of the auditory nerve represents an option to assess changes in auditory nerve responses and the interaction between the electrode and the neural tissue over time.

Aim: To study ECAP in children during the first year of CI use.

Material and methods: The ECAP characteristics have been analyzed in 13 children implanted younger than three years old. SERIES STUDY.

Descriptors:

Cochlear Implantation,cochlear nerve,child.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cochlear Nerve Disease Cranial Nerve Diseases Ear Diseases Nervous System Diseases Otorhinolaryngologic Diseases Retrocochlear Diseases Vestibulocochlear Nerve Diseases

Age range

Up to 3 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Universidade de São Paulo

Bauru, São Paulo, 17012-900, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

This study selected only children implanted younger than three years old and followed them during their first year of CI use.

Sponsors and collaborators

Lead sponsor

University of Sao Paulo

Other

Registry information

Acronym: ECAP

Important dates

Study start: 2005
Primary completion: 2006
First posted: Jul 31, 2008
Registry last updated: Mar 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed